One of the hallmarks of Alzheimer’s disease is the clumping of proteins called Tau, which form tangled fibrils in the brain. The more severe the clumping, the more advanced the disease is.
The Tau protein, which has also been linked to many other neurodegenerative diseases, is unstructured in its normal state, but in the pathological state it consists of a well-ordered rigid core surrounded by floppy segments. These disordered segments form a “fuzzy coat” that helps determine how Tau interacts with other molecules.
MIT chemists have now shown, for the first time, they can use nuclear magnetic resonance (NMR) spectroscopy to decipher the structure of this fuzzy coat. They hope their findings will aid efforts to develop drugs that interfere with Tau buildup in the brain.







